Brefeldin A prevents uncovering but not phosphorylation of the recognition marker in cathepsin D.
Brefeldin A (BFA) has been shown to inhibit transiently the subcellular transport of cathepsin D (Oda & Nishimura (1989) Biochem. Biophys. Res. Commun. 163, 220-225). We studied the effect of this antibiotic on processing of the phosphorylated oligosaccharides in cathepsin D in human promonocytes U937. In the presence of the drug the phosphorylation of cathepsin D precursor continued at a diminished rate. The phosphorylated oligosaccharides in cathepsin D comprised mono- and bis-phosphorylated forms. The relative amounts of the two species were not changed in the presence of BFA. The uncovering of the phosphate groups and the proteolytic processing of the phosphorylated precursor were abolished. In an in vitro assay the uncovering enzyme, N-acetylglucosamine-1-phosphodiester N-acetylglucosaminidase was not inhibited by BFA. We suggest that this drug interrupts the traffic between the compartments containing N-acetylglucosaminyl phosphotransferase and N-acetylglucosamine-1-phosphodiester N-acetylglucosaminidase.
Radons
J
J
Westfälische Wilhelms-Universität Münster, Institut für Physiologische Chemie und Pathobiochemie.
Isidoro
C
C
Hasilik
A
A
D001692:Biological Transport; D015415:Biomarkers; D020126:Brefeldin A; D002402:Cathepsin D / Q000378:metabolism*; D002478:Cells, Cultured; D003517:Cyclopentanes / Q000494:pharmacology*; D006801:Humans; D006868:Hydrolysis; D008360:Mannosephosphates / Q000378:metabolism; D010766:Phosphorylation; D013347:Subcellular Fractions / Q000187:drug effects / Q000378:metabolism
D015415:Biomarkers; D003517:Cyclopentanes; D008360:Mannosephosphates; D020126:Brefeldin A; C027693:mannose-6-phosphate; D002402:Cathepsin D